Home›Stock Screener›Sunrest Lifescience›Financial Statements

Sunrest Lifescience Financial Statements

7 Years of Data
2026 - 2020

Sunrest Lifescience financial statements. In FYNone, Sunrest Lifescience (SUNREST) reported revenue ₹19 Cr, net profit ₹2 Cr and EPS ₹6.60, with a net profit margin of 9.1% and ROE of 15.8%. Full financial statements from FY2020 to FY2026 (7 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Read Sunrest Lifescience dividend policy for the complete payout history and dividend yield track record.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 9.09% 2026 data
EBITDA Margin 15.15% 2026 data
Operating Margin 15.00% 2026 data
Return on Assets 7.32% 2026 data
Return on Equity 15.79% 2026 data

Balance Sheet Ratios

Current Ratio 4.13 2026 data
Equity Ratio 46.34% 2026 data
Asset Turnover 0.80 2026 data

SUNREST Revenue, Net Profit & EBITDA — Year-on-Year Growth

SUNREST YoY (March 2026 vs Period) — revenue -42.4%, net profit -33.3%, EBITDA -80.0%, expenses -35.7%. For live price, earnings ratios and company overview, see Sunrest Lifescience screener.

Revenue Growth
-42.4%
Year-over-Year
Net Profit Growth
-33.3%
Year-over-Year
EBITDA Growth
-80.0%
Year-over-Year
Expense Growth
-35.7%
Year-over-Year
Assets Growth
+17.1%
Year-over-Year
Equity Growth
+18.8%
Year-over-Year
Operating Cash Flow Growth
-100.0%
Year-over-Year
Investing Cash Flow Growth
-200.0%
Year-over-Year

SUNREST Income Statement — Revenue, EBITDA & Net Profit

Sunrest Lifescience revenue ₹19 Cr, EBITDA ₹1 Cr, net profit ₹2 Cr, EPS ₹6.60 (None) — net profit margin 9.1%. Analyse SUNREST shareholder distribution to track promoter, FII and institutional holdings.

Periods ₹ Crores
Particulars None March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Revenue 19 33 33 30 25 27 17 11
Expenses 18 28 30 29 22 26 17 11
EBITDA 1 5 3 1 3 1 0 0
Operating Profit Margin % 6.00% 15.00% 9.00% 3.00% 12.00% 4.00% 2.00% 1.00%
Depreciation 0 0 0 0 0 0 0 0
Interest 0 1 0 0 0 0 0 0
Profit Before Tax 1 4 3 1 3 1 0 0
Tax 0 1 1 0 1 0 0 0
Net Profit 2 3 2 0 2 1 0 0
Earnings Per Share (₹) 6.60 7.20 4.66 0.68 6.81 2.59 1.66 0.37

SUNREST Balance Sheet — Assets, Liabilities & Shareholders' Equity

SUNREST total assets ₹41 Cr, total equity ₹19 Cr, total liabilities ₹ Cr (2026) — ROE 15.8%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 41 35 25 17 13 10 6
Current Assets 33 28 25 16 13 9 6
Fixed Assets 3 1 0 0 1 0 0
Capital Work in Progress 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0
Other Assets 39 34 25 16 13 9 6
LIABILITIES
Total Liabilities
Current Liabilities 8 4 4 2 3 2 2
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 19 16 14 3 1 0 0
Share Capital 4 4 4 3 0 0 0
Reserves & Surplus 15 12 10 0 1 0 0

SUNREST Cash Flow Statement — Operating, Investing & Financing

Sunrest Lifescience operating cash flow ₹0 Cr, investing ₹-3 Cr, financing ₹4 Cr, net cash flow ₹1 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025
Operating Activities 0 3
Investing Activities -3 -1
Financing Activities 4 0
Net Cash Flow 1 2